PC_-_Glenmark_Q2FY20_Update_-_Nov_2019_20191115175030.pdf652 KBGlenmark Pharma (GNP IN) Core earnings concern remains INDIA | PHARMACEUTICALS | Quarterly Update#GLENMARK